百济神州补税风波:刚“摘U”即遇4.46亿元追缴,逾20家药企卷入,医药合规进入刚性时代

华夏时报网
Jul 01

4.46亿元补税计入2026年损益,刚刚扭亏为盈的百济神州,正在为一场突如其来的补税“埋单”。  2026年6月27日,百济神州一纸公告引发关注:公司一家境内全资子公司需补缴税款及滞纳金合计约4.46亿元。而就在不久前,这家创新药龙头刚刚摘掉“未盈利”的标签,首次实现年度盈利,并上调全年业绩指引。  但百济神州并非个案。截至2026年6月30日,年内已有20家医药公司披露补税公告,累计金额约16...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10